tm logo

Monitor this mark

View On USPTO

INCY
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 22 Jun 2022

Last Applicant/ Owned by

INCYTE HOLDINGS CORPORATION

1801 AUGUSTINE CUT-OFF

WILMINGTON

DE

19803

Serial Number

87022033 filed on 02th May 2016

Registration Number

5104367 registered on 20th Dec 2016

in the Principal Register

Correspondent Address

Frances M. Jagla

Frances M. Jagla

1201 Third Avenue, Suite 3600

Seattle WA 98101

Filing Basis

1. use application currently

Disclaimer

NO DATA

INCY

Pharmaceutical preparations for the treatment of viral, hematological, oncological, auto-immune, inflammatory, metabolic, and dermatological disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of viral, hematological, oncological, auto-immune, inflammatory, metabolic, and dermatological disorders

First Use Date in General

22nd Nov 2011

First Use Date in Commerce

22nd Nov 2011

Mark Details

Serial Number

No 87022033

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2854-T90US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Jun 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22nd Jun 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21st Jun 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11th Jan 2022TEAS SECTION 8 & 15 RECEIVED
20th Dec 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07th Jul 2020NOTICE OF SUIT
26th Jun 2020NOTICE OF SUIT
10th Apr 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10th Apr 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th Apr 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED